A man with stage 4 lung cancer presents with midshaft lytic lesions. What is a recommended treatment option besides morphine?

Prepare for the NBME Form 15 Test with our tailored quiz featuring flashcards and multiple-choice questions, each with hints and detailed explanations. Achieve success with our comprehensive study materials!

Multiple Choice

A man with stage 4 lung cancer presents with midshaft lytic lesions. What is a recommended treatment option besides morphine?

Explanation:
In the context of a patient with stage 4 lung cancer who presents with midshaft lytic lesions, radiation therapy is often a recommended treatment option to alleviate pain and manage metastatic lesions. Lytic bone lesions can indicate that the cancer has spread to the bones, leading to complications such as pain, fractures, and further morbidity. Radiation therapy is particularly effective in treating these painful bone metastases, as it can help to reduce pain by targeting the bone lesions directly. This approach can not only provide symptomatic relief but may also improve the quality of life for the patient. In this case, while options like surgery, chemotherapy, and targeted therapy might play roles in the overall management of the cancer, they may not address the immediate issue of pain control associated with the lytic lesions as effectively as radiation therapy does. Surgery could be risky and impractical given the stage of cancer, and chemotherapy and targeted therapy typically focus on systemic disease control rather than localized bone pain relief. Thus, radiation therapy stands out as the most appropriate adjunct treatment in this scenario.

In the context of a patient with stage 4 lung cancer who presents with midshaft lytic lesions, radiation therapy is often a recommended treatment option to alleviate pain and manage metastatic lesions. Lytic bone lesions can indicate that the cancer has spread to the bones, leading to complications such as pain, fractures, and further morbidity.

Radiation therapy is particularly effective in treating these painful bone metastases, as it can help to reduce pain by targeting the bone lesions directly. This approach can not only provide symptomatic relief but may also improve the quality of life for the patient.

In this case, while options like surgery, chemotherapy, and targeted therapy might play roles in the overall management of the cancer, they may not address the immediate issue of pain control associated with the lytic lesions as effectively as radiation therapy does. Surgery could be risky and impractical given the stage of cancer, and chemotherapy and targeted therapy typically focus on systemic disease control rather than localized bone pain relief. Thus, radiation therapy stands out as the most appropriate adjunct treatment in this scenario.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy